COVID-19:Yamasa 向辉瑞和 Moderna 供应 mRNA 原材料

Vaccine, flu, bio, Medical science, Pharmaceutical

COVID-19:Chugai 扩大了抗体鸡尾酒疗法的适应症:Lonapreve™

Vaccine, flu, medical service, Pharmaceutical

Shionogi:开始电晕口服药物的商业化生产:年底前批准申请

flu, Drugs, Pharmaceutical

COVID-19:Shionogi,电晕药物的最终临床试验:S-217622

flu, Drugs, Pharmaceutical

法匹拉韦会进入北美吗?

flu, Drugs, Pharmaceutical

Posts navigation